World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
26929
World Ranking
19302
National Ranking
9617

Andres M. Salazar publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Andres M. Salazar sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 321 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Andres M. Salazar D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Andres M. Salazar sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 74 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Andres M. Salazar is affiliated with Oncovir in the United States and has contributed extensively to the fields of medicine, immunology and microbiology, and biochemistry, genetics, and molecular biology. Their research spans several subfields, notably immunology, molecular biology, oncology, epidemiology, and genetics.

Their work focuses on primary topics including immunotherapy and immune responses, cancer immunotherapy and biomarkers, vaccines and immunoinformatics approaches, immune cell function and interaction, glycosylation and glycoproteins research, glioma diagnosis and treatment, and CAR-T cell therapy research.

Salazar's notable recent papers include:

  • Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma, 2020, Journal of Clinical Investigation
  • Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets, 2020, Nature Cancer
  • Poly-ICLC, a multi-functional immune modulator for treating cancer, 2020, Seminars in Immunology
  • Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration, 2020, Journal for ImmunoTherapy of Cancer
  • Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy, 2024, Nature

Frequent co-authors who have collaborated with Salazar include Otávia L. Caballero, Ricardo T. Gazzinelli, Hideho Okada, Julia Castro, and Natália Satchiko Hojo-Souza.

The scientist's research has been published primarily in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Clinical Investigation
  • Journal for ImmunoTherapy of Cancer
  • npj Vaccines
  • Neuro-Oncology

Best Publications

  • Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis

    Lawrence D. Jacobs;Diane L. Cookfair;Richard A. Rudick;Robert M. Herndon

  • An immunogenic personal neoantigen vaccine for patients with melanoma

    Patrick A. Ott;Zhuting Hu;Derin B. Keskin;Derin B. Keskin;Sachet A. Shukla;Sachet A. Shukla

  • Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

    Derin B. Keskin;Annabelle J. Anandappa;Jing Sun;Itay Tirosh

  • Frontal lobe injuries, violence, and aggression: A report of the Vietnam Head Injury Study

    Jordan Grafman;Karen Schwab;D. Warden;A. Pridgen

  • Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

    Katrin D. Mayer-Barber;Bruno B. Andrade;Sandra D. Oland;Eduardo P. Amaral;Eduardo P. Amaral

  • Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.

    M. P. Heyes;K. Saito;J. S. Crowley;L. E. Davis

  • Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.

    Hideho Okada;Pawel Kalinski;Ryo Ueda;Aki Hoji

  • Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant.

    M. Paula Longhi;Christine Trumpfheller;Juliana Idoyaga;Marina Caskey

  • Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status.

    Melvyn P. Heyes;Bruce J. Brew;Alex Martin;Richard W. Price

  • Epilepsy after penetrating head injury. I. Clinical correlates: a report of the Vietnam Head Injury Study.

    Andres M. Salazar;Bahman Jabbari;Stephen C. Vance;Jordan Grafman

  • A longitudinal study of brain atrophy in relapsing multiple sclerosis

    J. H. Simon;L. D. Jacobs;M. K. Campion;R. A. Rudick

  • Neuropsychological effects of interferon β‐1a in relapsing multiple sclerosis

    Jill S. Fischer;Roger L. Priore;Lawrence D. Jacobs;Diane L. Cookfair

  • Magnetic resonance studies of intramuscular interferon β-1a for relapsing multiple sclerosis

    Jack H. Simon;Lawrence D. Jacobs;Marilyn Campion;Karl Wende

  • Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination.

    Linda Hammerich;Thomas U. Marron;Ranjan Upadhyay;Judit Svensson-Arvelund

  • Long-term morbidities following self-reported mild traumatic brain injury

    Rodney D. Vanderploeg;Glenn Curtiss;Cheryl A. Luis;Andres M. Salazar

  • Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans

    Marina Caskey;François Lefebvre;Abdelali Filali-Mouhim;Mark J. Cameron

  • Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis

    R. A. Rudick;D. E. Goodkin;L. D. Jacobs;D. L. Cookfair

  • Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population

    Lis R.V. Antonelli;Antonio Gigliotti Rothfuchs;Ricardo Gonçalves;Ester Roffê

  • Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

    Paul Sabbatini;Takemasa Tsuji;Luis Ferran;Erika Ritter

  • MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study

    Takashi Kimura;John R. McKolanis;Lynda A. Dzubinski;Kazi Islam

Frequent Co-Authors

Hideho Okada
Hideho Okada University of California, San Francisco
Lisa H. Butterfield
Lisa H. Butterfield University of California, San Francisco
Sandra Zurawski
Sandra Zurawski Baylor University
Nina Bhardwaj
Nina Bhardwaj Icahn School of Medicine at Mount Sinai
Patrick A. Ott
Patrick A. Ott Harvard University
Gerard Zurawski
Gerard Zurawski Baylor University
Gad Getz
Gad Getz Broad Institute
Nir Hacohen
Nir Hacohen Harvard University
Sachet A. Shukla
Sachet A. Shukla The University of Texas MD Anderson Cancer Center
Eric S. Lander
Eric S. Lander Broad Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens diverse pathways beyond traditional doctor roles. Many students explore online degrees in nursing, healthcare administration, and advanced practice nursing to broaden their career options.

If you're interested in healthcare leadership, consider cahme accredited online healthcare administration programs. These programs help prepare graduates for high-demand management roles within hospitals and medical organizations.

Registered Nurses seeking to advance their qualifications quickly may benefit from rn to bsn online programs without clinicals. These flexible programs allow nurses to earn a bachelor's degree without on-site clinical requirements.

For nurses aiming for the highest levels of clinical expertise, dnp online programs offer an efficient route to a Doctor of Nursing Practice degree. Some students prioritize convenience and a lighter workload, and for them, dnp programs with more accessible requirements are available.

Whether you want to advance in patient care or lead healthcare systems, these related online degrees present flexible learning opportunities to match your career goals.

Best Scientists Citing Andres M. Salazar

Trending Scientists

Recently Published Articles